Post-COVID-19 Complications and their Laboratory Findings: A Cohort Study

• Published in: Archives of Razi Institute Vol. 78; no. 2; pp. 715 - 720
• Main Authors: Othman Qadir, G, Omar Ahmed, K, Ahmed Saleh, B, Ahmed Hamad Ameen, K, Mustafa Mawlud, I, Jalal Taher, H
• Format: Journal Article
• Language: English
• Published: Iran Razi Vaccine & Serum Research Institute 30.04.2023
• Subjects: Original; LDH; Coronavirus; Post COVID-19 Complication; Chest pain
• ISSN: 0365-3439; 2008-9872
• DOI: 10.22092/ARI.2022.359721.2462

Type 2 severe acute respiratory syndrome caused by coronavirus infection has become the most well-known pandemic infectious viral disease in the present century. This study aims to find out the post-COVID-19 infection complications via a well-designed observational study. A total of 986 recovered cases (only the period ranged between 2 to 3 months after recovery) were obtained from public and private hospitals in Kirkuk and Erbil governorates\Iraq. The admitted patients were asked to answer a questionnaire through interviews; the laboratory findings were obtained from the patients. The results suggested that approximately half of post-COVID-19 patients (%45.606) were suffering from chest pain, while (%32.357) of the cases suffered headache and chest pain. Liver enzymes (ALT, AST, and ALP) showed abnormal percent values of 38.6,24.07, and 26.09, respectively. Renal function enzymes, mainly urea, were found to be abnormal in 45.37% of recovered individuals. Furthermore, abnormal LDH levels were found in (77.9%) of post-COVID-19 patients. This finding revealed that chest pain was an inflammatory condition and liver and renal enzyme disturbances, while elevation in LDH was the predominant long-term complication in post-COVID-19 patients.